Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 11
Corrigendum
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,849 | Dovepress* | 8,631+ | 1,530 | 10,161 | |
| PubMed Central* | 218 | 79 | 297 | ||
| Totals | 8,849 | 1,609 | 10,458 | ||
| *Since 14 January 2019 | |||||
View citations on PubMed Central and Google Scholar